Trial Outcomes & Findings for A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A (NCT NCT01895088)

NCT ID: NCT01895088

Last Updated: 2017-08-01

Results Overview

The change in the number of lines of threshold visual acuity achieved postoperatively.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

271 participants

Primary outcome timeframe

Baseline and 2 years

Results posted on

2017-08-01

Participant Flow

Participant milestones

Participant milestones
Measure
Patients Prev. Implanted With ACI7000PDT
Prev. implanted in ACU-P08-020/020A study AcuFocus Corneal Inlay ACI 7000 PDT: corneal inlay
Overall Study
STARTED
271
Overall Study
COMPLETED
253
Overall Study
NOT COMPLETED
18

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Age, Categorical
n=271 Participants
Measure Type: Count of Participants
Age, Categorical
<=18 years
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
271 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
Sex: Female, Male
Female
146 Participants
n=5 Participants
Sex: Female, Male
Male
125 Participants
n=5 Participants
Region of Enrollment
United States
271 participants
n=5 Participants

PRIMARY outcome

Timeframe: Baseline and 2 years

The change in the number of lines of threshold visual acuity achieved postoperatively.

Outcome measures

Outcome measures
Measure
Patients Prev. Implanted With ACI7000PDT
n=271 Participants
Prev. implanted in ACU-P08-020/020A study AcuFocus Corneal Inlay ACI 7000 PDT: Inlay implanted in cornea for improvement of near vision
Change (Increase) in Uncorrected Near Visual Acuity
3.1 lines of visual acuity improvement
Standard Deviation 1.7

Adverse Events

Patients Prev. Implanted With ACI7000PDT

Serious events: 10 serious events
Other events: 23 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Patients Prev. Implanted With ACI7000PDT
n=271 participants at risk
Prev. implanted in ACU-P08-020/020A study AcuFocus Corneal Inlay ACI 7000 PDT: corneal inlay
Nervous system disorders
Cerebrovascular Accident
0.37%
1/271 • Number of events 1 • Two years
General disorders
Carcinoma
0.37%
1/271 • Number of events 1 • Two years
Musculoskeletal and connective tissue disorders
Motorcycle Accident
0.37%
1/271 • Number of events 1 • Two years
Reproductive system and breast disorders
Breast Cancer
0.37%
1/271 • Number of events 1 • Two years
Surgical and medical procedures
Joint Replacement Surgery
1.1%
3/271 • Number of events 3 • Two years
Surgical and medical procedures
Benign Brain Tumor
0.37%
1/271 • Number of events 1 • Two years
Surgical and medical procedures
Cyst Removal
0.37%
1/271 • Number of events 1 • Two years
Surgical and medical procedures
Appendicitis
0.37%
1/271 • Number of events 1 • Two years

Other adverse events

Other adverse events
Measure
Patients Prev. Implanted With ACI7000PDT
n=271 participants at risk
Prev. implanted in ACU-P08-020/020A study AcuFocus Corneal Inlay ACI 7000 PDT: corneal inlay
Eye disorders
Blepharitis
0.37%
1/271 • Number of events 1 • Two years
Eye disorders
Secondary Surgical Intervention
1.5%
4/271 • Number of events 4 • Two years
Eye disorders
Superficial Punctate Keratitis
0.37%
1/271 • Number of events 1 • Two years
Eye disorders
Conjunctival cyst
0.37%
1/271 • Number of events 1 • Two years
Eye disorders
Retinal pigment epithelium granularity
0.37%
1/271 • Number of events 1 • Two years
Eye disorders
Corneal abrasion
0.37%
1/271 • Number of events 1 • Two years
Eye disorders
Vision
5.2%
14/271 • Number of events 14 • Two years

Additional Information

Eugenia Thomas, Director Clinical Trials

AcuFocus, Inc.

Phone: 9495859511

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place